Knight Therapeutics Inc.
GUD.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.06% | 521.98% | -17.18% | -4,517.98% | -542.81% |
| Total Depreciation and Amortization | 20.45% | 44.25% | 8.53% | 31.41% | -8.84% |
| Total Amortization of Deferred Charges | -- | -- | 6.37% | -- | -- |
| Total Other Non-Cash Items | 104.10% | 126.92% | 91.98% | 195.90% | 2,111.75% |
| Change in Net Operating Assets | -87.68% | 173.35% | 197.22% | -2.58% | 207.65% |
| Cash from Operations | 42.01% | 1,044.33% | 2,283.63% | 100.64% | 1,944.21% |
| Capital Expenditure | 2.41% | -820.24% | 9.45% | -8.57% | 10.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | 92.31% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.96% | -56.11% | -122.13% | -81.69% | -50.61% |
| Cash from Investing | 95.21% | -66.33% | -125.50% | -112.08% | -952.38% |
| Total Debt Issued | -- | -- | 59.67% | -- | 14,544.44% |
| Total Debt Repaid | 31.30% | -362.89% | -274.70% | -65.02% | -606.28% |
| Issuance of Common Stock | 78.79% | -1.75% | -5.00% | -71.88% | 6.76% |
| Repurchase of Common Stock | -17,200.00% | -146.25% | 41.73% | -- | 99.52% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.79% | -14.06% | -1.03% | -103.78% | 7.19% |
| Cash from Financing | -178.06% | -368.00% | -127.57% | -49.01% | 542.29% |
| Foreign Exchange rate Adjustments | 139.31% | 87.77% | -142.10% | 261.54% | -204.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.83% | 1.75% | -185.80% | -68.95% | -1,574.59% |